Proteobacteria: A Common Factor in Human Diseases
- PMID: 29230419
- PMCID: PMC5688358
- DOI: 10.1155/2017/9351507
Proteobacteria: A Common Factor in Human Diseases
Abstract
Microbiota represents the entire microbial community present in the gut host. It serves several functions establishing a mutualistic relation with the host. Latest years have seen a burst in the number of studies focusing on this topic, in particular on intestinal diseases. In this scenario, Proteobacteria are one of the most abundant phyla, comprising several known human pathogens. This review highlights the latest findings on the role of Proteobacteria not only in intestinal but also in extraintestinal diseases. Indeed, an increasing amount of data identifies Proteobacteria as a possible microbial signature of disease. Several studies demonstrate an increased abundance of members belonging to this phylum in such conditions. Major evidences currently involve metabolic disorders and inflammatory bowel disease. However, more recent studies suggest a role also in lung diseases, such as asthma and chronic obstructive pulmonary disease, but evidences are still scant. Notably, all these conditions are sustained by various degree of inflammation, which thus represents a core aspect of Proteobacteria-related diseases.
Similar articles
-
Proteobacteria: microbial signature of dysbiosis in gut microbiota.Trends Biotechnol. 2015 Sep;33(9):496-503. doi: 10.1016/j.tibtech.2015.06.011. Epub 2015 Jul 22. Trends Biotechnol. 2015. PMID: 26210164 Review.
-
Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction.Curr Opin Microbiol. 2017 Oct;39:1-6. doi: 10.1016/j.mib.2017.07.003. Epub 2017 Aug 4. Curr Opin Microbiol. 2017. PMID: 28783509 Review.
-
Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In-silico study.PLoS One. 2017 Jul 5;12(7):e0180518. doi: 10.1371/journal.pone.0180518. eCollection 2017. PLoS One. 2017. PMID: 28678867 Free PMC article.
-
[The human intestinal microbiota].Gastroenterol Clin Biol. 2010 Sep;34 Suppl 1:S7-15. doi: 10.1016/S0399-8320(10)70015-4. Gastroenterol Clin Biol. 2010. PMID: 20889008 French.
-
Convergent temporal dynamics of the human infant gut microbiota.ISME J. 2010 Feb;4(2):151-8. doi: 10.1038/ismej.2009.96. Epub 2009 Aug 27. ISME J. 2010. PMID: 19710708
Cited by
-
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome.BMC Gastroenterol. 2021 Mar 5;21(1):105. doi: 10.1186/s12876-021-01693-w. BMC Gastroenterol. 2021. PMID: 33663411 Free PMC article.
-
Resveratrol and its derivative pterostilbene ameliorate intestine injury in intrauterine growth-retarded weanling piglets by modulating redox status and gut microbiota.J Anim Sci Biotechnol. 2021 Jun 10;12(1):70. doi: 10.1186/s40104-021-00589-9. J Anim Sci Biotechnol. 2021. PMID: 34108035 Free PMC article.
-
The Threat of Potentially Pathogenic Bacteria in the Feces of Bats.Microbiol Spectr. 2022 Dec 21;10(6):e0180222. doi: 10.1128/spectrum.01802-22. Epub 2022 Oct 26. Microbiol Spectr. 2022. PMID: 36287057 Free PMC article.
-
Evaluation of digestively resistant or soluble fibers, short- and medium-chain fatty acids, trace minerals, and antibiotics in nonchallenged nursery pigs on performance, digestibility, and intestinal integrity.J Anim Sci. 2022 Nov 1;100(11):skac282. doi: 10.1093/jas/skac282. J Anim Sci. 2022. PMID: 36130296 Free PMC article.
-
Effects of Dietary Ursolic Acid on Growth Performance and Intestinal Health of Largemouth Bass (Micropterus salmoides).Animals (Basel). 2024 Aug 27;14(17):2492. doi: 10.3390/ani14172492. Animals (Basel). 2024. PMID: 39272277 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical